Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Letter
  • Published:

Non-effect of p22-phox −930A/G polymorphism on end-organ damage in Brazilian hypertensive patients

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Cifuentes ME, Pagano PJ . Targeting reactive oxygen species in hypertension. Curr Opin Nephrol Hypertens 2006; 15: 179–186.

    Article  CAS  Google Scholar 

  2. Nadruz Jr W, Lagosta VJ, Moreno Jr H, Coelho OR, Franchini KG . Simvastatin prevents load-induced protein tyrosine nitration in overloaded hearts. Hypertension 2004; 43: 1060–1066.

    Article  CAS  Google Scholar 

  3. Moreno MU, San Jose G, Orbe J, Paramo JA, Beloqui O, Díez J et al. Preliminary characterisation of the promoter of the human p22phox gene: identification of a new polymorphism associated with hypertension. FEBS Lett 2003; 542: 27–31.

    Article  CAS  Google Scholar 

  4. San Jose G, Moreno MU, Olivan S, Beloqui O, Fortuno A, Diez J et al. Functional effect of the p22phox −930A/G polymorphism on p22phox expression and NADPH oxidase activity in hypertension. Hypertension 2004; 44: 163–169.

    Article  CAS  Google Scholar 

  5. Borges MC, Colombo RC, Goncalves JG, Ferreira JO, Franchini KG . Longitudinal mitral annulus velocities are reduced in hypertensive subjects with or without left ventricle hypertrophy. Hypertension 2006; 47: 854–860.

    Article  CAS  Google Scholar 

  6. Kokubo Y, Iwai N, Tago N, Inamoto N, Okayama A, Yamawaki H et al. Association analysis between hypertension and CYBA, CLCNKB, and KCNMB1 functional polymorphisms in the japanese population. Circ J 2005; 69: 138–142.

    Article  CAS  Google Scholar 

  7. Heymes C, Bendall JK, Ratajczak P, Cave AC, Samuel JL, Hasenfuss G et al. Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 2003; 41: 2164–2171.

    Article  CAS  Google Scholar 

  8. Jones SA, Hancock JT, Jones OT, Neubauer A, Topley N . The expression of NADPH oxidase components in human glomerular mesangial cells: detection of protein and mRNA for p47phox, p67phox, and p22phox. J Am Soc Nephrol 1995; 5: 1483–1491.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W Nadruz Jr.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sales, M., Ferreira, M., Leme, C. et al. Non-effect of p22-phox −930A/G polymorphism on end-organ damage in Brazilian hypertensive patients. J Hum Hypertens 21, 504–506 (2007). https://doi.org/10.1038/sj.jhh.1002170

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1002170

This article is cited by

Search

Quick links